Organised by the European School of Haematology (ESH), the 6th International Conference on Acute Myeloid Leukemia (AML) was successfully held in Estoril, Portugal on 29-31 October 2023.
We are thrilled to have our researchers participated in the conference and poster presentation which provided them an opportunity to showcase their current project “Decitabine and immune activation in TP53 mutated MDS/AML”, funded under the Centre for Oncology and Immunology.
This conference, with a focus on the theme “Molecular and Translational – Advances in Biology and Treatment”, gathered renowned AML researchers and physicians from around the world to share novel insights on the current status and exciting developments in the field. It was truly an inspiring event, fostering meaningful connections among participants and giving great value to the research community.
We look forward to continuing our research and providing a conducive environment for young scientist to flourish!